Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2018-03-26 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE TRANSACTION SUBSCRIPTION OF INTEREST IN LIMITED PARTNERSHIP
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a discloseable transaction involving the subscription of interest in a limited partnership by the company. It details the terms of the subscription agreement, the parties involved, the investment objectives, and the implications under the Listing Rules. The document is a formal announcement of a capital investment transaction and does not contain financial statements, earnings data, or management discussion of results. It is not a full financial report, audit report, or earnings release. The content fits the category of Capital/Financing Update as it relates to the company's financing activities and investment commitments. The document length and detail support it being a substantive announcement rather than a brief notice or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-03-26 English
FURTHER ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO PROVISION OF FINANCIAL ASSISTANCE
Capital/Financing Update Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding a waiver granted by the Stock Exchange related to the interest rate of a loan, which is part of a previously disclosed transaction involving financial assistance. The document references prior announcements and provides an update but does not contain financial statements or detailed financial data. It is short (1747 characters) and serves as an update to previous disclosures rather than a full report. This fits the category of Capital/Financing Update (CAP), as it relates to financing activities and capital structure changes.
2018-03-19 English
CLARIFICATION ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a clarification announcement related to a previous announcement about the subscription of shares. It corrects the expected return rate for Class A shares from 8.5% to 7.5% per annum. The document is short (1716 characters) and serves to clarify a prior announcement rather than presenting new financial data or a report. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report like an Annual Report or Interim Report, nor is it a regulatory certification or voting result. It is an announcement clarifying a previous announcement, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2018-03-16 English
MAJOR TRANSACTION SUBSCRIPTION OF SHARES IN SEGREGATED PORTFOLIO COMPANY
Capital/Financing Update Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding a major transaction involving the subscription of shares in a Segregated Portfolio Company. It details the terms of the investment, the subscription agreement, the loan agreement, and the regulatory implications under the Hong Kong Listing Rules. The document is structured as a formal announcement with detailed transaction terms and regulatory disclosures, typical of a capital or financing update. It is not a full financial report, earnings release, or management discussion. It also does not fit categories like merger/acquisition, board changes, or voting results. The key indicators are the description of a major transaction, subscription agreement, investment amount, and regulatory compliance under Listing Rules Chapter 14, which are characteristic of a Capital/Financing Update filing.
2018-03-15 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors about the date of a board meeting to consider and approve the consolidated annual results for the nine months ended 31 December 2017 and the publication of that announcement. It does not contain the actual financial results or detailed report but merely informs about the upcoming meeting and the intention to release results. The document length is short (1459 characters) and it is clearly an announcement of a report to be published later, not the report itself. Therefore, according to the 'Menu vs Meal' rule, this is a Regulatory Filing (RNS) as a general announcement about the timing of financial results publication, not the actual Interim/Quarterly Report or Annual Report.
2018-03-15 English
FURTHER ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO PROVISION OF FINANCIAL ASSISTANCE
Capital/Financing Update Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding an amendment agreement to extend the repayment date of a loan, which is described as a discloseable transaction under the Listing Rules. It discusses financial assistance, loan terms, and the implications under the stock exchange rules. The document is relatively short (3477 characters) and focuses on a specific transaction related to financing. There is no detailed financial data or comprehensive report content, but rather an update on a capital/financing event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-03-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.